Publications

Found 1 results
Filters: Author is M.H. Ghattas  [Clear All Filters]
2011
M. A. Amer, Ghattas, M. H., Abo-ElMatty, D. M., and Abou-El-Ela, S. H., Influence of glutathione S-transferase polymorphisms on type-2 diabetes mellitus risk, vol. 10, pp. 3722-3730, 2011.
Ada AO, Suzen SH and Iscan M (2004). Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population. Toxicol. Lett. 151: 311-315. http://dx.doi.org/10.1016/j.toxlet.2003.12.075 PMid:15177667   American Diabetes Association (2007). Diagnosis and classification of diabetes mellitus. Diabetes Care 30 (Suppl 1): 47.   Baynes JW (1991). Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412. http://dx.doi.org/10.2337/diabetes.40.4.405 PMid:2010041   Bessa SS, Ali EM and Hamdy SM (2009). The role of glutathione S- transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension. Eur. J. Intern. Med. 20: 625-630. http://dx.doi.org/10.1016/j.ejim.2009.06.003 PMid:19782926   Bid HK, Konwar R, Saxena M, Chaudhari P, et al. (2010). Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J. Postgrad. Med. 56: 176-181. http://dx.doi.org/10.4103/0022-3859.68633 PMid:20739761   D'Alo F, Voso MT, Guidi F, Massini G, et al. (2004). Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. Haematologica 89: 664-670. PMid:15194533   Delles C, Padmanabhan S, Lee WK, Miller WH, et al. (2008). Glutathione S-transferase variants and hypertension. J. Hypertens. 26: 1343-1352. http://dx.doi.org/10.1097/HJH.0b013e3282fe1d67 PMid:18551009   Doney AS, Lee S, Leese GP, Morris AD, et al. (2005). Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation 111: 2927-2934. http://dx.doi.org/10.1161/CIRCULATIONAHA.104.509224 PMid:15927971   Douglas KT (1987). Mechanism of action of glutathione-dependent enzymes. Adv. Enzymol. Relat. Areas Mol. Biol. 59: 103-167. PMid:2880477   Garte S, Gaspari L, Alexandrie AK, Ambrosone C, et al. (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10: 1239-1248. PMid:11751440   Gorogawa S, Kajimoto Y, Umayahara Y, Kaneto H, et al. (2002). Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res. Clin. Pract. 57: 1-10. http://dx.doi.org/10.1016/S0168-8227(02)00005-0   Gsur A, Haidinger G, Hinteregger S, Bernhofer G, et al. (2001). Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int. J. Cancer 95: 152-155. http://dx.doi.org/10.1002/1097-0215(20010520)95:3<152::AID-IJC1026>3.0.CO;2-S   Hayes JD and McLellan LI (1999). Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic. Res. 31: 273-300. http://dx.doi.org/10.1080/10715769900300851 PMid:10517533   Hayes JD and Strange RC (2000). Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61: 154-166. http://dx.doi.org/10.1159/000028396 PMid:10971201   Hori M, Oniki K, Ueda K, Goto S, et al. (2007). Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against type 2 diabetes in Japanese. Pharmacogenomics 8: 1307-1314. http://dx.doi.org/10.2217/14622416.8.10.1307 PMid:17979505   London SJ, Yuan JM, Chung FL, Gao YT, et al. (2000). Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 356: 724-729. http://dx.doi.org/10.1016/S0140-6736(00)02631-3   Maritim AC, Sanders RA and Watkins JB, III (2003). Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17: 24-38. http://dx.doi.org/10.1002/jbt.10058 PMid:12616644   Pemble S, Schroeder KR, Spencer SR, Meyer DJ, et al. (1994). Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300: 271-276. PMid:8198545 PMCid:1138152   Shaikh RS, Amir M, Masood AI, Sohail A, et al. (2010). Frequency distribution of GSTM1 and GSTT1 null allele in Pakistani population and risk of disease incidence. Environ. Toxicol. Pharmacol. 30: 76-79. http://dx.doi.org/10.1016/j.etap.2010.04.002 PMid:21787632   Shaw JE, Sicree RA and Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87: 4-14. http://dx.doi.org/10.1016/j.diabres.2009.10.007 PMid:19896746   Sheehan D, Meade G, Foley VM and Dowd CA (2001). Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 360: 1-16. http://dx.doi.org/10.1042/0264-6021:3600001 PMid:11695986 PMCid:1222196   Stephens JW, Khanolkar MP and Bain SC (2009). The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202: 321-329. http://dx.doi.org/10.1016/j.atherosclerosis.2008.06.006 PMid:18640680   Wang G, Zhang L and Li Q (2006). Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population. Biochem. Biophys. Res. Commun. 341: 310-313. http://dx.doi.org/10.1016/j.bbrc.2005.12.195 PMid:16413497   Wild S, Roglic G, Green A, Sicree R, et al. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053. http://dx.doi.org/10.2337/diacare.27.5.1047 PMid:15111519